GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

alizapride   Click here for help

GtoPdb Ligand ID: 11141

Synonyms: Limican® | Litican® | Nausilex® | Plitican® | Superan® | Vergentan®
Approved drug
alizapride is an approved drug
Compound class: Synthetic organic
Comment: Dopamine D2 receptor antagonist with prokinetic and antiemetic effects which can also be used in the treatment of nausea and vomiting, including postoperative nausea and vomiting. The WHO INN record for alizapride provides the CAS registry number 59338-93-1. This CAS number maps to PubChem CID 135413504 (vergentan), which is a tautomer of alizapride.
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/). All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 83.14
Molecular weight 315.17
XLogP 1.53
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

✖
Canonical SMILES C=CCN1CCCC1CNC(=O)c1cc2[nH]nnc2cc1OC
Isomeric SMILES C=CCN1CCCC1CNC(=O)c1cc2[nH]nnc2cc1OC
InChI InChI=1S/C16H21N5O2/c1-3-6-21-7-4-5-11(21)10-17-16(22)12-8-13-14(19-20-18-13)9-15(12)23-2/h3,8-9,11H,1,4-7,10H2,2H3,(H,17,22)(H,18,19,20)
InChI Key KSEYRUGYKHXGFW-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

For advanced searching click here to open chemical structure editor

Similar Ligands Click here for help
sulpiride
Click here for ligand page
Targets
D2 receptor; D3 receptor; carbonic anhydrase 1; carbonic anhydrase 12; carbonic anhydrase 7
[3H]raclopride
Click here for ligand page
Targets
D2 receptor
eticlopride
Click here for ligand page
Targets
D2 receptor; D3 receptor; D4 receptor
amisulpride
Click here for ligand page
Targets
D2 receptor; D3 receptor
(+)-sulpiride
Click here for ligand page
Targets
D2 receptor; D3 receptor; D4 receptor
(-)-sulpiride
Click here for ligand page
Targets
D2 receptor; D3 receptor; D4 receptor
raclopride
Click here for ligand page
Targets
5-HT1A receptor; D2 receptor; D3 receptor; D4 receptor
nafadotride
Click here for ligand page
Targets
5-HT1A receptor; D2 receptor; D3 receptor; D4 receptor